Biotechnology UltraSector ProFund

The Biotechnology UltraSector ProFund seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the S&P Biotechnology Select Industry Index.

About the Fund

Investor Class
  • Ticker BIPIX
  • CUSIP 743185480
  • Fund Number 43
  • NAV (as of 6/14/2024) $62.09
  • NAV Change $-2.19 ( -3.41%) down caret
Service Class
  • Ticker BIPSX
  • CUSIP 743185472
  • Fund Number 73
  • NAV (as of 6/14/2024) $39.04
  • NAV Change $-1.37 (-3.39%) down caret
Details
  • Inception Date 6/19/2000
  • Fund Group UltraSector ProFunds
  • Limits on Exchanges None
  • Minimum Investment (Individual) $15,000
  • Minimum Investment (Financial Professional) $5,000
  • Gross Expense Ratio 1.54%
  • Net Expense Ratio* 1.54%
Investor Class
  • Ticker BIPIX
  • CUSIP 743185480
  • Fund Number 43
  • NAV (as of 6/14/2024) $62.09
  • NAV Change $-2.19 (-3.41%) down caret
Service Class
  • Ticker BIPSX
  • CUSIP 743185472
  • Fund Number 73
  • NAV (as of 6/14/2024) $39.04
  • NAV Change $-1.37 (-3.39%) down caret
Details
  • Inception Date 6/19/2000
  • Fund Group UltraSector ProFunds
  • Limits on Exchanges None
  • Minimum Investment (Individual) $15,000
  • Minimum Investment (Financial Professional) $5,000
  • Gross Expense Ratio 1.54%
  • Net Expense Ratio* 1.54%

*Contractual waiver effective from December 1, 2023 through November 30, 2024. Without such a waiver of fees, the total returns may have been lower.

All data, unless otherwise noted, is for Investor Class Shares only and is subject to change.

Total Return

Fund 1m 3m YTD 1Y 3Y 5Y 10Y Since Inception Gross Expense
Ratio (%)
Net Expense
Ratio
Inception Date
Biotechnology UltraSector ProFund 7.41% -15.39% -3.47% 1.54% 0.98% 11.90% 8.03% 6.87% 1.54% 1.54% 06/19/2000

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.

Index

as of 3/28/2024

  • Total Number of Companies133
  • Price/Earnings Ratio0
  • Price/Book Ratio5.93
  • Dividend Yield ( % )0.11
  • Avg. Index Market Capitalization$9.30 billion
S&P Biotechnology Select Industry Index

The Index represents the biotechnology segment of the S&P Total Market Index (“S&P TMI”). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the following Global Industry Classification Standard (GICS®) sub-industry: biotechnology.

Exposures

Index as of 3/28/2024



Sum of weightings may not equal 100% due to rounding. These percentages are allowed to fluctuate between semi-annual reconstitution dates and may be higher or lower than the indicated amounts until they are reset at the next Index reconstitution date.

Distributions

There is no guarantee that dividends or interest income will be paid.